Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization

Status unconfirmed

Conditions studied: Systemic Lupus Erythematosus, Lupus, Lupus Erythematosus, Lupus Erythematosus, Systemic

In brief

To develop a test to characterize and monitor SLE disease activity status from a participant's home by analyzing the gene expression from participant self-collected blood samples using a novel fingerstick collection kit.

Key facts

Study ID

NCT03142412

Run by

DxTerity Diagnostics

People needed

2500

Starts

2017-04-17

Expected to finish

2021-10-17

Last updated by the study team

2018-06-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female patients age 18 or older
• Have a permanent address in the United States for the duration of the study
• Have an email address and access to the internet for the duration of the study
• Able to provide informed consent
• Self-reported diagnosis of lupus

You may not qualify if…

• None

Where it is running

• DxTerity Diagnostics — Compton, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.